loader
Please Wait
Applying Filters...

Euroapi Company Header Euroapi Company Header

X

Related Intermediates: CAS 3934-20-1

Client Email Product
Menu
Left Arrow
Right Arrow
Filters Filter
Cross PopUp
FILTER :

filter

01 Suanfarma (2)

02 Cohance Lifesciences (2)

03 Malladi Drugs & Pharmaceuticals Limited (1)

04 Valsynthese (1)

05 Aarti Pharmalabs (3)

06 Aptra Synthesis (1)

07 JSC Olainfarm (1)

08 Jinan Tantu Chemicals (1)

09 Shandong Boyuan Pharmaceutical (6)

10 Tagoor Laboratories (4)

11 USV Private Limited (1)

12 Anhui HaiKang Pharmaceutical Co. Ltd (6)

13 Bulat Pharmaceutical (2)

14 Dasami Lab (2)

15 Delta Finochem P Ltd (1)

16 Epoch Labs (1)

17 Guangdong Raffles PharmaTech Co Ltd (6)

18 Hangzhou Longshine Bio-Tech Co.,LTD (3)

19 Kekule Pharma (5)

20 LinkChem (2)

21 Luna Chemicals (2)

22 Ningbo Syntame Biotech (3)

23 Ocimum Labs (4)

24 Octane Laboratories (6)

25 Prajna Generics (1)

26 Reliance Rasayan (1)

27 Riddhesh Pharmachem (3)

28 SGMR Pharmaceuticals (1)

29 Sagar Life Sciences (1)

30 Sandoo Pharmaceuticals and Chemcials Co.,Ltd (1)

31 Shanghai Fine Pharma (6)

32 Shenzhen HwaGen Pharmaceutical (3)

33 Srini Pharmaceuticals (2)

34 Suraj Labs (1)

35 Synthland Limited (3)

36 Vidgas Science & Technologies (12)

37 Wavelength Pharmaceuticals (3)

152460-10-1
Imatinib Mesylate
Suanfarma founded in 1993, is a B2B life science partner committed to health & innovation by developing, ...
Suanfarma founded in 1993, is a B2B life science partner committed to health & innovation by developing, manufacturing, & distributing high-quality APIs for the pharmaceutical industry innovatively & sustainably. Backed by a robust global network of 12 strategically located local offices, we cater to the needs of over 400 active customers in 70+ countries. At Suanfarma we offer our CDMO capacity for fermentation & chemical synthesis projects, offering a One Stop Shop service with a solid track record, & which allows us to achieve success in the development, scaling, manufacturing, & commercialization of an API, either innovative or generic.
106261-64-7
Imatinib Mesylate
Suanfarma founded in 1993, is a B2B life science partner committed to health & innovation by developing, ...
Suanfarma founded in 1993, is a B2B life science partner committed to health & innovation by developing, manufacturing, & distributing high-quality APIs for the pharmaceutical industry innovatively & sustainably. Backed by a robust global network of 12 strategically located local offices, we cater to the needs of over 400 active customers in 70+ countries. At Suanfarma we offer our CDMO capacity for fermentation & chemical synthesis projects, offering a One Stop Shop service with a solid track record, & which allows us to achieve success in the development, scaling, manufacturing, & commercialization of an API, either innovative or generic.
1075705-01-9
Osimertinib Mesylate
Cohance Lifesciences is a leading CDMO and API platform, offering products and services across all phases...
Cohance Lifesciences is a leading CDMO and API platform, offering products and services across all phases of a molecule’s lifecycle from development to commercialzation. With our expertise in complex chemistries, we provide end-to-end CDMO services to global innovators and have delivered numerous projects from concept to commercialization over the years.As a global API player, we serve customers across nearly 60 countries with 80+ molecules backed by robust R&D, regulatory capabilities and manufacturing infrastructure. We are among the top backward integrated exporters of pellets and have strong development and manufacturing capabilities.
1421372-94-2
Osimertinib Mesylate
Cohance Lifesciences is a leading CDMO and API platform, offering products and services across all phases...
Cohance Lifesciences is a leading CDMO and API platform, offering products and services across all phases of a molecule’s lifecycle from development to commercialzation. With our expertise in complex chemistries, we provide end-to-end CDMO services to global innovators and have delivered numerous projects from concept to commercialization over the years.As a global API player, we serve customers across nearly 60 countries with 80+ molecules backed by robust R&D, regulatory capabilities and manufacturing infrastructure. We are among the top backward integrated exporters of pellets and have strong development and manufacturing capabilities.
152460-07-6
Imatinib Mesylate
Malladi Drugs & Pharmaceuticals Ltd was founded in 1980 by microbiologist Mr. M L N Sastry. Within a few ...
Malladi Drugs & Pharmaceuticals Ltd was founded in 1980 by microbiologist Mr. M L N Sastry. Within a few years, Malladi established itself as a leader in manufacturing ephedrine and pseudoephedrine salts. Today, it is the leading manufacturer of APIs in the cough and cold segment. It also has a dominant presence in several therapeutic segments like antihistamines, anti-convulsants, anti-depressants and anxiolytics (CNS). Malladi exports its products to around 60 countries and over 85% of its revenue is generated from exports. Its manufacturing facilities have been approved by the FDA, EDQM, KFDA, TGA and various other regulatory agencies.
20191-74-6
Valsynthese, a privately held CDMO, is a member of the SSE Group. Headquartered in Brig, Switzerland, it ...
Valsynthese, a privately held CDMO, is a member of the SSE Group. Headquartered in Brig, Switzerland, it has a broad international reach. With over a century of experience in highly hazardous and energetic chemistry, it has the expertise to develop fine chemical projects and has established the capability to produce key chemical intermediates and APIs under GMP and ISO certification. Valsynthese is regarded as one of Europe's most experienced CDMO chemical producers. It offers a variety of projects, ranging from lab procedures to tonne-scale manufacturing. It supplies its customers with high-quality products at competitive prices.
1075705-01-9
Osimertinib Mesylate
Aarti Pharmalab, earlier the pharma division of Aarti Industries, is a leading Indian manufacturer of API...
Aarti Pharmalab, earlier the pharma division of Aarti Industries, is a leading Indian manufacturer of APIs. It has dedicated facilities to manufacture HPAPIs, corticosteroids, cytotoxic & oncology products. It has 2 R&D centers & 3 cGMP plants successfully audited by the USFDA, EUGMP, EDQM, KFDA & COFEPRIS. It also offers CDMO services for generic APIs & NCEs, intermediates & key building blocks.

Note: None of the products will be supplied to countries in which this could be in conflict with existing patents. Further, any products under patent will be offered for R&D purposes only. However, the final responsibility lies with the buyer.

Aarti Industries Company Banner

IPS 2024

Not Confirmed

envelop Contact Supplier
1032452-86-0
Osimertinib Mesylate
Aarti Pharmalab, earlier the pharma division of Aarti Industries, is a leading Indian manufacturer of API...
Aarti Pharmalab, earlier the pharma division of Aarti Industries, is a leading Indian manufacturer of APIs. It has dedicated facilities to manufacture HPAPIs, corticosteroids, cytotoxic & oncology products. It has 2 R&D centers & 3 cGMP plants successfully audited by the USFDA, EUGMP, EDQM, KFDA & COFEPRIS. It also offers CDMO services for generic APIs & NCEs, intermediates & key building blocks.

Note: None of the products will be supplied to countries in which this could be in conflict with existing patents. Further, any products under patent will be offered for R&D purposes only. However, the final responsibility lies with the buyer.

Aarti Industries Company Banner

IPS 2024

Not Confirmed

envelop Contact Supplier
1421372-94-2
Osimertinib Mesylate
Aarti Pharmalab, earlier the pharma division of Aarti Industries, is a leading Indian manufacturer of API...
Aarti Pharmalab, earlier the pharma division of Aarti Industries, is a leading Indian manufacturer of APIs. It has dedicated facilities to manufacture HPAPIs, corticosteroids, cytotoxic & oncology products. It has 2 R&D centers & 3 cGMP plants successfully audited by the USFDA, EUGMP, EDQM, KFDA & COFEPRIS. It also offers CDMO services for generic APIs & NCEs, intermediates & key building blocks.

Note: None of the products will be supplied to countries in which this could be in conflict with existing patents. Further, any products under patent will be offered for R&D purposes only. However, the final responsibility lies with the buyer.

Aarti Industries Company Banner

IPS 2024

Not Confirmed

envelop Contact Supplier
350-03-8
Imatinib Mesylate
Aptra Synthesis Private Limited, is a reliable and vertically integrated manufacturer of APIs and interme...
Aptra Synthesis Private Limited, is a reliable and vertically integrated manufacturer of APIs and intermediates, boasting state-of-the-art manufacturing facilities that adhere to GMP standards. We take great pride in producing top-notch intermediates through our fully backward-integrated process. Aptra Synthesis Private Limited (ASPL) stands as one of the rapidly emerging manufacturers of Active Pharmaceutical Ingredients (APIs), Pellets (Semi-finished Formulations), and Intermediates.
Aptra Synthesis

IPS 2024

Not Confirmed

envelop Contact Supplier
Post Enquiry
POST ENQUIRY